Es gab 50 kürzliche Insider-Transaktionen für Rigel Pharmaceuticals, Inc. (RIGL), darunter 28 Käufe und 20 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $6.68M und die gesamten Insider-Verkäufe auf $3.46M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Moos Walter H, Rodriguez Raul R, Schorno Dean L. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — RIGL
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-20 |
Moos Walter H |
Director |
Optionsausübung (Verkauf) |
4,000 |
$24.00 |
$96K |
- |
| 2026-02-17 |
Rodriguez Raul R |
CEO, President |
RSU-Zuteilung |
53,915 |
- |
- |
282,017 |
| 2026-02-17 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Zuteilung |
20,636 |
- |
- |
76,337 |
| 2026-02-17 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Zuteilung |
19,497 |
- |
- |
51,813 |
| 2026-02-17 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
19,430 |
- |
- |
62,870 |
| 2026-02-17 |
Rojkjaer Lisa |
EVP, Chief Medical Officer |
RSU-Zuteilung |
18,894 |
- |
- |
34,853 |
| 2026-02-10 |
Rodriguez Raul R |
CEO, President |
RSU-Steuereinbehalt |
7,607 |
$34.62 |
$263.35K |
228,102 |
| 2026-02-10 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Steuereinbehalt |
3,546 |
$34.62 |
$122.76K |
55,701 |
| 2026-02-10 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Steuereinbehalt |
3,546 |
$34.62 |
$122.76K |
32,316 |
| 2026-02-10 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Steuereinbehalt |
3,546 |
$34.62 |
$122.76K |
43,440 |
| 2026-02-10 |
Rojkjaer Lisa |
EVP, Chief Medical Officer |
RSU-Steuereinbehalt |
3,758 |
$34.62 |
$130.1K |
15,959 |
| 2026-02-02 |
Rodriguez Raul R |
CEO, President |
RSU-Steuereinbehalt |
14,110 |
$36.01 |
$508.1K |
235,709 |
| 2026-02-02 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Steuereinbehalt |
5,488 |
$36.01 |
$197.62K |
59,247 |
| 2026-02-02 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Steuereinbehalt |
3,968 |
$36.01 |
$142.89K |
35,862 |
| 2026-02-02 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Steuereinbehalt |
5,718 |
$36.01 |
$205.91K |
46,986 |
| 2026-02-01 |
Miller Michael Patrick |
Director |
Unbekannt |
625 |
$16.05 |
$10.03K |
- |
| 2026-02-01 |
Miller Michael Patrick |
Director |
RSU-Zuteilung |
12,000 |
$34.86 |
$418.32K |
12,000 |
| 2026-01-26 |
Rodriguez Raul R |
CEO, President |
Optionsausübung (Verkauf) |
40,000 |
$27.40 |
$1.1M |
- |
| 2025-12-22 |
Schorno Dean L |
EVP & Chief Financial Officer |
Optionsausübung (Verkauf) |
1,667 |
$18.70 |
$31.17K |
10,832 |
| 2025-09-15 |
Rodriguez Raul R |
CEO, President |
RSU-Zuteilung |
31,700 |
$22.49 |
$712.93K |
31,700 |
| 2025-09-15 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Zuteilung |
7,394 |
$22.49 |
$166.29K |
7,394 |
| 2025-09-15 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Zuteilung |
7,394 |
$22.49 |
$166.29K |
7,394 |
| 2025-09-15 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
7,394 |
$22.49 |
$166.29K |
7,394 |
| 2025-09-15 |
Rojkjaer Lisa |
EVP, Chief Medical Officer |
RSU-Zuteilung |
7,394 |
$22.49 |
$166.29K |
7,394 |
| 2025-05-23 |
Moos Walter H |
Director |
RSU-Zuteilung |
3,000 |
$18.95 |
$56.85K |
3,000 |
| 2025-05-23 |
Lapointe Anthony Gregg |
Director |
RSU-Zuteilung |
3,000 |
$18.95 |
$56.85K |
3,000 |
| 2025-05-23 |
Wasman Jane |
Director |
RSU-Zuteilung |
3,000 |
$18.95 |
$56.85K |
3,000 |
| 2025-05-23 |
Frohlich Mark W |
Director |
RSU-Zuteilung |
1,250 |
- |
- |
1,250 |
| 2025-05-23 |
Hannah Alison L. |
Director |
RSU-Zuteilung |
3,000 |
$18.95 |
$56.85K |
3,000 |
| 2025-05-23 |
Ali-jackson Kamil |
Director |
RSU-Zuteilung |
3,000 |
$18.95 |
$56.85K |
3,000 |
| 2025-03-17 |
Rodriguez Raul R |
CEO, President |
RSU-Zuteilung |
26,250 |
$35.40 |
$929.25K |
26,250 |
| 2025-03-17 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Zuteilung |
5,625 |
$35.40 |
$199.13K |
5,625 |
| 2025-03-17 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Zuteilung |
7,850 |
$12.70 |
$99.7K |
7,850 |
| 2025-03-17 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
6,875 |
$35.40 |
$243.38K |
6,875 |
| 2025-03-17 |
Rojkjaer Lisa |
EVP, Chief Medical Officer |
RSU-Zuteilung |
9,375 |
$14.90 |
$139.69K |
9,375 |
| 2025-03-06 |
Frohlich Mark W |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-03-06 |
Frohlich Mark W |
Director |
RSU-Zuteilung |
12,000 |
$19.70 |
$236.4K |
12,000 |
| 2025-02-05 |
Rodriguez Raul R |
CEO, President |
Informierter Verkauf |
4,400 |
$21.93 |
$96.47K |
239,454 |
| 2025-02-05 |
Schorno Dean L |
EVP & Chief Financial Officer |
Informierter Verkauf |
1,734 |
$21.93 |
$38.02K |
57,235 |
| 2025-02-05 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
Informierter Verkauf |
1,339 |
$21.93 |
$29.36K |
38,830 |
| 2025-02-05 |
Santos David A |
EVP, Chief Commercial Officer |
Informierter Verkauf |
1,796 |
$21.93 |
$39.38K |
51,704 |
| 2025-02-04 |
Rodriguez Raul R |
CEO, President |
Informierter Verkauf |
4,952 |
$20.92 |
$103.6K |
243,854 |
| 2025-02-04 |
Schorno Dean L |
EVP & Chief Financial Officer |
Informierter Verkauf |
2,036 |
$20.92 |
$42.6K |
58,969 |
| 2025-02-04 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
Informierter Verkauf |
1,448 |
$20.92 |
$30.29K |
40,169 |
| 2025-02-04 |
Santos David A |
EVP, Chief Commercial Officer |
Informierter Verkauf |
2,125 |
$20.92 |
$44.46K |
53,500 |
| 2025-01-29 |
Rodriguez Raul R |
CEO, President |
RSU-Zuteilung |
63,400 |
$22.49 |
$1.43M |
63,400 |
| 2025-01-29 |
Schorno Dean L |
EVP & Chief Financial Officer |
RSU-Zuteilung |
14,788 |
$22.49 |
$332.58K |
14,788 |
| 2025-01-29 |
Furey Raymond J. |
EVP, Gc, Cco & Corp Sec |
RSU-Zuteilung |
14,788 |
$22.49 |
$332.58K |
14,788 |
| 2025-01-29 |
Santos David A |
EVP, Chief Commercial Officer |
RSU-Zuteilung |
14,788 |
$22.49 |
$332.58K |
14,788 |
| 2025-01-29 |
Rojkjaer Lisa |
EVP, Chief Medical Officer |
RSU-Zuteilung |
14,788 |
$22.49 |
$332.58K |
14,788 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
